CYTOIMMUNE THERAPEUTICS INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Canada and Colombia. Its main competitors in its focus markets biotechnology and pharmaceuticals are INST GRIFOLS S A, CYTOIMMUNE THERAPEUTICS LLC and CELL DESIGN LABS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | Colombia | 2 | |
#4 | Singapore | 2 | |
#5 | United States | 2 | |
#6 | Brazil | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Caligiuri Michael | 12 |
#2 | Yu Jianhua | 12 |
#3 | Jianhua Yu | 1 |
#4 | Michael Caligiuri | 1 |
#5 | Devine Steven | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021050591A1 | Bispecific antibody car cell immunotherapy | |
EP3765042A1 | Bispecific antibody car cell immunotherapy |